Knopp Biosciences LLC-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Knopp Biosciences LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013975
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Knopp Biosciences LLC (Knopp Biosciences) is a drug discovery and development company that develops and markets medicines for the treatment of neurological disorders. The company’s lead product candidate, dexpramipexole, is an orally bioavailable small molecule which is used for the treatment of asthma, other eosinophil-associated disorders, and for amyotrophic lateral sclerosis (ALS). Its mitochondrial modulators are used for the treatment of neurodegenerative disorders; and ion channel modulators for epilepsy and neuropathic pain. It also collaborates with investigators, practitioners and pharmaceutical companies. Knopp Biosciences is headquartered in Pittsburgh, Pennsylvania, the US.

Knopp Biosciences LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Knopp Biosciences LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Knopp Biosciences LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Knopp Biosciences LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Knopp Biosciences LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Knopp Biosciences LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Knopp Biosciences LLC, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Knopp Biosciences Raises USD17.1 Million in Venture Financing 10
Knopp Biosciences Raises USD3 Million in Venture Financing 11
Knopp Biosciences Raises US$15 Million In First Tranche Of Venture Financing 12
Partnerships 13
Albany Molecular Enters Into An Agreement With Knopp Biosciences For Discovery Services 13
Knopp Biosciences LLC – Key Competitors 14
Knopp Biosciences LLC – Key Employees 15
Knopp Biosciences LLC – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Corporate Communications 17
Mar 21, 2017: Knopp Biosciences Announces Election of Biotech Executive Shane Kovacs to Board of Managers 17
Government and Public Interest 18
Oct 23, 2017: Knopp Biosciences Announces Renewal of NIH Blueprint Grant Award for Advancing KCNQ2 Modulators in Epilepsy 18
Product News 19
12/14/2016: Steroid-Sparing Effects of Dexpramipexole in Hypereosinophilic Syndromes (HES) Reported at American Society of Hematology 2016 Annual Meeting 19
03/21/2017: Knopp Biosciences Announces Election of Biotech Executive Shane Kovacs to Board of Managers 20
03/07/2017: Knopp Biosciences Announces Publication of Eosinophil-Lowering Effects of Dexpramipexole in Multiple Clinical Trials 21
Clinical Trials 22
Feb 16, 2017: Knopp Biosciences Announces NIH Blueprint Grant Award 22
Jan 10, 2016: Cytokinetics Presents Analyses Demonstrating Predictive Value of Slow Vital Capacity for Clinical Outcomes in ALS 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
Knopp Biosciences LLC, Pharmaceuticals & Healthcare, Key Facts 2
Knopp Biosciences LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Knopp Biosciences LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Knopp Biosciences LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Knopp Biosciences LLC, Deals By Therapy Area, 2011 to YTD 2017 8
Knopp Biosciences LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Knopp Biosciences Raises USD17.1 Million in Venture Financing 10
Knopp Biosciences Raises USD3 Million in Venture Financing 11
Knopp Biosciences Raises US$15 Million In First Tranche Of Venture Financing 12
Albany Molecular Enters Into An Agreement With Knopp Biosciences For Discovery Services 13
Knopp Biosciences LLC, Key Competitors 14
Knopp Biosciences LLC, Key Employees 15

★海外企業調査レポート[Knopp Biosciences LLC-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The Pack Corporation:企業の戦略・SWOT・財務分析
    The Pack Corporation - Strategy, SWOT and Corporate Finance Report Summary The Pack Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • CytoSorbents Corp (CTSO)-製薬・医療分野:企業M&A・提携分析
    Summary CytoSorbents Corp (CytoSorbents), formerly MedaSorb Technologies Corp, is a critical care immunotherapy company that specializes in the development of blood purification products. Its flagship product, CytoSorb is an extracorporeal cytokine adsorber that is designed to control extreme system …
  • BOC Aviation Limited (2588):企業の財務・戦略的SWOT分析
    BOC Aviation Limited (2588) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Sensile Medical AG:医療機器:M&Aディール及び事業提携情報
    Summary Sensile Medical AG (Sensile) is a medical device company that develops and produces key technologies for liquid drug delivery devices. The company develops products in the areas of micro insulin delivery and glucose monitoring systems. Its pipeline products comprise sensepatch and senseflex. …
  • Sharps Compliance Corp (SMED):企業の財務・戦略的SWOT分析
    Summary Sharps Compliance Corp (Sharps) is a healthcare waste solution company that offers regulatory compliant services. The company offers products such as sharps disposal systems, public sharps safety, takeaway medication recovery system, collection and disposal system, complete needle collection …
  • GlaxoSmithkline Consumer Healthcare Ltd:企業の戦略・SWOT・財務情報
    GlaxoSmithkline Consumer Healthcare Ltd - Strategy, SWOT and Corporate Finance Report Summary GlaxoSmithkline Consumer Healthcare Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • China Energy Conservation and Environmental Protection Group-エネルギー分野:企業M&A・提携分析
    Summary China Energy Conservation and Environmental Protection Group (CECEP) is a clean technology company that offers energy conservation, emission reduction and environment protection services. The company provides clean energy, energy saving, environmental protection, integrated services and reso …
  • Pier 1 Imports, Inc.:企業の戦略・SWOT・財務情報
    Pier 1 Imports, Inc. - Strategy, SWOT and Corporate Finance Report Summary Pier 1 Imports, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Ciber Global, LLC:企業の戦略・SWOT・財務分析
    Ciber Global, LLC - Strategy, SWOT and Corporate Finance Report Summary Ciber Global, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Check Point Software Technologies Ltd.:企業の戦略・SWOT・財務分析
    Check Point Software Technologies Ltd. - Strategy, SWOT and Corporate Finance Report Summary Check Point Software Technologies Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Genome Institute of Singapore:医療機器:M&Aディール及び事業提携情報
    Summary Genome Institute of Singapore (GIS) is a research institute that provides research programs and services in different areas. The institute concentrates on genomic sciences to improve public health and prosperity in Singapore. It operates technology and comprises early career researchers such …
  • The Capital Group Companies, Inc.:企業の戦略・SWOT・財務情報
    The Capital Group Companies, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Capital Group Companies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Hyundai Steel Co:企業の戦略・SWOT・財務情報
    Hyundai Steel Co - Strategy, SWOT and Corporate Finance Report Summary Hyundai Steel Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • PT Adaro Energy Tbk:企業の戦略・SWOT・財務情報
    PT Adaro Energy Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Adaro Energy Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • KPMG International Coop:企業の戦略的SWOT分析
    KPMG International Coop - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Midsona AB (MSON B):企業の財務・戦略的SWOT分析
    Summary Midsona AB (Midsona), formerly Midelfart Sonesson AB is a healthcare products manufacturing company that provides personal care products, health foods, and hygiene products. The company’s products include superfood, sports nutrition, dietary supplements, nutritional supplements, organic food …
  • Pfenex Inc (PFNX):企業の財務・戦略的SWOT分析
    Summary Pfenex Inc (Pfenex) is a biologics company that develops biosimilar therapeutics. The company’s lead product candidate includes, PF582, a biosimilar candidate which is used for the treatment of retinal diseases. It also develops PF530, a biosimilar candidate for the treatment of multiple scl …
  • VolitionRX Ltd (VNRX):企業の財務・戦略的SWOT分析
    Summary VolitionRX Ltd (VolitionRX) is a medical equipment provider that develops diagnostics tests for cancer and other conditions. The company develops Nucleosomics, a platform technology used for measurement and identification of nucleosomes in the blood. It develops tools for the diagnosis of va …
  • Commercial International Bank (Egypt) SAE:企業の戦略・SWOT・財務情報
    Commercial International Bank (Egypt) SAE - Strategy, SWOT and Corporate Finance Report Summary Commercial International Bank (Egypt) SAE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Shire plc:企業のM&A・事業提携・投資動向
    Shire plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Shire plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆